{
  "id": "3997b4dc1ab3549a",
  "title": "Phase 3 MajesTEC - 9 Trial Shows Survival Benefit With Teclistamab in Multiple Myeloma",
  "description": "20260116T004500Z",
  "content": "",
  "source": "pharmacytimes.com",
  "source_url": "https://www.pharmacytimes.com/view/phase-3-majestec-9-trial-shows-survival-benefit-with-teclistamab-in-multiple-myeloma",
  "published_at": "20260116T004500Z",
  "fetched_at": "2026-01-17T00:22:29.333379+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmacytimes.com/view/phase-3-majestec-9-trial-shows-survival-benefit-with-teclistamab-in-multiple-myeloma",
    "url_mobile": "",
    "title": "Phase 3 MajesTEC - 9 Trial Shows Survival Benefit With Teclistamab in Multiple Myeloma",
    "seendate": "20260116T004500Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/fc2622df6f44b14a0a3ccf3694133914a60fa1a9-10000x6600.jpg",
    "domain": "pharmacytimes.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}